Fosun Pharma's XH-S004 Innovative Drug Secures Global Licensing Deal Worth $645 Million Fosun Pharma's subsidiary has entered a licensing agreement for its innovative drug XH-S004, potentially yielding $645 million through development and sales milestones.

Fosun Pharma's XH-S004 Innovative Drug Secures Global Licensing Deal Worth $645 Million #Shanghai #Fosun_Pharma #XH-S004 #Expedition_Therapeutics